EGFR and breast cancer: Overexpressed in various tumors, including breast cancer, the epidermal growth factor receptor (EGFR) was detected using an immune tandem mass spectrometry (iMALDI) diagnostic assay based on MALDI-MS to assess the molecular weight of the epitope-containing peptides and MALDI-MS/MS to perform their amino acid sequence [161].